Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

Comparisons of prognostic factors between young and elderly patients with chronic heart failure.

Sato T, Yamauchi H, Kanno Y, Suzuki S, Yoshihisa A, Yamaki T, Sugimoto K, Kunii H, Nakazato K, Suzuki H, Saitoh S, Takeishi Y.

Geriatr Gerontol Int. 2015 Apr;15(4):435-42. doi: 10.1111/ggi.12293. Epub 2014 Apr 15.

PMID:
24730674
2.

Diastolic function and BNP changes during exercise predict oxygen consumption in chronic heart failure patients.

Ciampi Q, Borzillo G, Barbato E, Petruzziello B, Betocchi S, Villari B.

Scand Cardiovasc J. 2009 Feb;43(1):17-23. doi: 10.1080/14017430802175720.

PMID:
18609042
3.
4.

Greater prognostic value of peak VO2 after exercise training program completion in heart failure patients.

Tabet JY, Meurin P, Benzidi Y, Beauvais F, Ben Driss A, Weber H, Renaud N, Dumaine R, Grosdemouge A, Cohen Solal A.

Int J Cardiol. 2013 Oct 9;168(4):4139-44. doi: 10.1016/j.ijcard.2013.07.076. Epub 2013 Aug 1.

PMID:
23911267
5.

Prognostic value of changes over time in exercise capacity and echocardiographic measurements in patients with chronic heart failure.

Florea VG, Henein MY, Anker SD, Francis DP, Chambers JS, Ponikowski P, Coats AJ.

Eur Heart J. 2000 Jan;21(2):146-53.

PMID:
10637088
6.

Is hormonal activation during exercise useful for risk stratification in patients with moderate congestive heart failure?

de Groote P, Soudan B, Lamblin N, Rouaix-Emery N, Mc Fadden E, Meurice T, Mouquet F, Bauters C.

Am Heart J. 2004 Aug;148(2):349-55.

PMID:
15309008
7.

Prognostic value of a new cardiopulmonary exercise testing parameter in chronic heart failure: oxygen uptake efficiency at peak exercise - comparison with oxygen uptake efficiency slope.

Toste A, Soares R, Feliciano J, Andreozzi V, Silva S, Abreu A, Ramos R, Santos N, Ferreira L, Ferreira RC.

Rev Port Cardiol. 2011 Oct;30(10):781-7. doi: 10.1016/S0870-2551(11)70026-9.

PMID:
22118129
8.

Value of peak exercise oxygen consumption combined with B-type natriuretic peptide levels for optimal timing of cardiac transplantation.

Kato TS, Collado E, Khawaja T, Kawano Y, Kim M, Farr M, Mancini DM, Schulze PC.

Circ Heart Fail. 2013 Jan;6(1):6-14. doi: 10.1161/CIRCHEARTFAILURE.112.968123. Epub 2012 Nov 30.

9.

Brain natriuretic peptide kinetics during dynamic exercise in patients with chronic heart failure.

Krüger S, Graf J, Merx MW, Stickel T, Kunz D, Hanrath P, Janssens U.

Int J Cardiol. 2004 May;95(1):49-54.

PMID:
15159038
10.

Comparison of plasma N-brain natriuretic peptide, peak oxygen consumption, and left ventricular ejection fraction for severity of chronic heart failure.

Williams SG, Ng LL, O'Brien RJ, Taylor S, Li YF, Tan LB.

Am J Cardiol. 2004 Jun 15;93(12):1560-1.

PMID:
15194038
11.
12.

Augmented response in plasma brain natriuretic peptide to dynamic exercise in patients with left ventricular dysfunction and congestive heart failure.

Kato M, Kinugawa T, Ogino K, Endo A, Osaki S, Igawa O, Hisatome I, Shigemasa C.

J Intern Med. 2000 Oct;248(4):309-15.

13.

Risk stratification in chronic heart failure: independent and incremental prognostic value of echocardiography and brain natriuretic peptide and its N-terminal fragment.

Bruch C, Rothenburger M, Gotzmann M, Sindermann J, Scheld HH, Breithardt G, Wichter T.

J Am Soc Echocardiogr. 2006 May;19(5):522-8.

PMID:
16644435
14.

Peak cardiac power measured noninvasively with a bioreactance technique is a predictor of adverse outcomes in patients with advanced heart failure.

Rosenblum H, Helmke S, Williams P, Teruya S, Jones M, Burkhoff D, Mancini D, Maurer MS.

Congest Heart Fail. 2010 Nov-Dec;16(6):254-8. doi: 10.1111/j.1751-7133.2010.00187.x. Epub 2010 Oct 19.

15.

Gender differences in variables related to B-natriuretic peptide, left ventricular ejection fraction and mass, and peak oxygen consumption, in patients with heart failure.

Tasevska-Dinevska G, Kennedy LM, Cline-Iwarson A, Cline C, Erhardt L, Willenheimer R.

Int J Cardiol. 2011 Jun 16;149(3):364-71. doi: 10.1016/j.ijcard.2010.02.018. Epub 2010 Mar 3.

PMID:
20202706
16.

Comparison of the prognostic usefulness of N-terminal pro-brain natriuretic Peptide in patients with heart failure with versus without chronic kidney disease.

Bruch C, Fischer C, Sindermann J, Stypmann J, Breithardt G, Gradaus R.

Am J Cardiol. 2008 Aug 15;102(4):469-74. doi: 10.1016/j.amjcard.2008.03.082. Epub 2008 May 24.

PMID:
18678308
17.

The predictive capacity and additional prognostic power of N-terminal pro-B-type natriuretic peptide in Chinese elderly with chronic heart failure.

Fu S, Xie L, Li D, Ye P, Luo L.

Clin Interv Aging. 2015 Jan 27;10:359-65. doi: 10.2147/CIA.S77417. eCollection 2015.

18.

Oxygen uptake efficiency slope correlates with brain natriuretic peptide in patients with heart failure.

Straburzyńska-Migaj E, Gwizdała A, Siniawski A, Ochotny R, Grajek S.

Cardiol J. 2010;17(4):362-6.

19.

Multiparametric risk stratification in patients with mild to moderate chronic heart failure.

Scardovi AB, De Maria R, Coletta C, Aspromonte N, Perna S, Cacciatore G, Parolini M, Ricci R, Ceci V.

J Card Fail. 2007 Aug;13(6):445-51.

PMID:
17675058
20.

Usefulness of non-invasive measurement of cardiac output during sub-maximal exercise to predict outcome in patients with chronic heart failure.

Goda A, Lang CC, Williams P, Jones M, Farr MJ, Mancini DM.

Am J Cardiol. 2009 Dec 1;104(11):1556-60. doi: 10.1016/j.amjcard.2009.07.025. Epub 2009 Oct 14.

PMID:
19932792

Supplemental Content

Support Center